Form 4 for AVXL ANAVEX LIFE SCIENCES CORP.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001731122-24-000828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-15 | AVXL | Thomas Steffen | Dir | P - Purchase | $4.52 | +5,000 | 5,000 | New | +$22.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | P | A | 5,000 | $4.52 | 5,000 | D | — | — | (F1) Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.92 |